Sinje Gehr

“In 2016, the Charité – Universitätsmedizin Berlin launched an initiative for patients with MS. Its goal is to improve the quality of clinical MS trials. After discussions with the Federal Chancellery, the Federal Ministry of Health and pharmaceutical companies, the Charité developed a concept for achieving this goal. The concept was based on the US Forum for Collaborative HIV Research. As a neutral institution, the initiative now connects patient representatives, MS experts, authorities and institutions in the health care system, as well as research-based pharmaceutical companies, in order to jointly submit proposals at an early stage for the design of studies on drug therapy. Special attention is also paid to patient-relevant endpoints and the development of studies and registries to gain better insight into the benefits and harms of MS drugs in the post-approval period.”